Marcos Antonio Fernandes de Oliveira

Marcos Antonio Fernandes de Oliveira

Auto-generated profile, based on publicly available information

Marcos Antonio Fernandes de Oliveira

Department of Biochemistry, Institute of Chemistry, University of São Paulo (USP), São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2025 in Archives of Medical Research
Verified
Journal Article
Closed access
PSPatrick Vieira Souza
Patrick Vieira Souza
AAAriana Musa Aquino
Ariana Musa Aquino
LALuiz Guilherme Alonso-Costa
Luiz Guilherme Alonso-Costa
NMNatália Magosso
Natália Magosso
MOMarcos Antonio Fernandes de Oliveira
Marcos Antonio Fernandes de Oliveira
WSWellerson Rodrigo Scarano
Wellerson Rodrigo Scarano

3 November 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MOMarcos Antonio F. de Oliveira
Marcos Antonio F. de Oliveira
VSVitor L. da Silva
Vitor L. da Silva
TTThaise L. Teixeira
Thaise L. Teixeira
FGFernanda M. Gerolamo
Fernanda M. Gerolamo
TGTarcillo J. N. Gaziri
Tarcillo J. N. Gaziri
Marcelo Santos da SilvaMarcelo Santos da Silva
Marcelo Santos da Silva
The thymidine analogs 5-bromo-2′-deoxyuridine (BrdU) and 5-ethynyl-2′-deoxyuridine (EdU) are widely used to monitor DNA synthesis. Although studies have reported EdU toxicity in certain cell types, no reports to date describe genotoxic effects associated with BrdU/EdU use in trypanosomatids, etiological agents of neglected tropical diseases. This lack of studies raises two possibilities: either these nucleotides are not toxic to these parasites, or the observed genotoxicity was not relevant under the experimental conditions used. Here, we assessed the potential toxicity of BrdU and EdU across three pathogenic trypanosomatids: Trypanosoma cruzi , Trypanosoma brucei , and Leishmania major. Our findings show that EdU has greater genotoxic potential than BrdU. Nevertheless, trypanosomatids respond markedly differently to DNA alterations caused by this analog: T. cruzi cells stop replicating and accumulate in S phase, T. brucei tolerates the DNA lesions generated, while part of the L. major population appears to display an ‘altruistic’ behavior that benefits the survivors. Furthermore, in silico assays suggest that, once incorporated into DNA, the ethynyl group increases the EdU’s polarity, thereby altering DNA structure more strongly than BrdU does after the first round of DNA replication. Together, our findings suggest that using thymidine analogs in trypanosomatids should be preceded by rigorous preliminary analysis, especially when using EdU. Otherwise, the data may be biased by a BrdU/EdU-triggered DNA damage response. We believe this study may serve as an atlas to guide the initial selection of thymidine analog concentrations and exposure periods. Graphical